Kardiale Erkrankungen


In der postnatalen Phase ist der Kreislauf erheblichen Umstellungsvorgängen unterworfen. Dadurch werden z.B. einige in utero gut tolerierte angeborene Herzfehler unmittelbar post natum symptomatisch. Bedeutsam ist hierbei außerdem, da߸ das Herz des Neugeborenen schon physiologischerweise auf der Ebene eines hohen enddiastolischen Füllungsvolumens arbeitet, die myokardiale Kate-cholaminkonzentration in den ersten Lebenstagen besonders niedrig [31] und die Utilisation langkettiger Fettsäuren gegenüber dem Erwachsenen eingeschränkt [24] ist.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Achanti B, Yeh TF, Pildes RS (1986) Indomethacin therapy in infants with advanced postnatal age and patent ductus arteriosus. Clin Invest Med 9:250–253PubMedGoogle Scholar
  2. 2.
    Appleton RS, Graham TP Jr, Cotton RB, Moreau GA, Boucek RJ Jr (1988) Decreased early diastolic function after indomethacin administration in premature infants. J Pediatr 112:447–451PubMedCrossRefGoogle Scholar
  3. 3.
    Artman M, Graham TP Jr (1987) Guidelines for vasodilator therapy of congestive heart failure in infants and children. Am Heart J 113:994–1005PubMedCrossRefGoogle Scholar
  4. 4.
    Bancalari E, Sinclair JC (1992) Mechanical ventilation. In: Sinclair JC, Bracken MB (eds) Effective care of the newborn infant. Oxford Univ Press, Oxford, pp 214–215Google Scholar
  5. 4a.
    Baum M, Chinnock R, Ashwal S, Peverini R, Trimm F, Baley L (1993) Growth and neurodevelopmental outcome of infants undergoing heart transplantation. Heart Lung Transplant 12:S211–S217Google Scholar
  6. 5.
    Beekman RH, Rocchini AP, Dick IM, Crowley DC, Rosenthal A (1984) Vasodilator therapy in children: Acute and chronic effects in children with left ventricular dysfunction or mitral regurgitation. Pediatrics 73:43–51PubMedGoogle Scholar
  7. 6.
    Borghi A, Agnoletti G, Valsecchi O, Carminati M (1999) Aortic balloon dilatation for congenital aortic stenosis: report of 90 cases (1986–98). Heart 82:el0Google Scholar
  8. 7.
    Brackley KJ, Kilby MD, Wright JG et al. (2000) Outcome after prenatal diagnosis of hypoplastic left-heart syndrom: a case series. Lancet 356: 1143–1147PubMedCrossRefGoogle Scholar
  9. 8.
    Camm AJ, Garratt CJ (1991) Adenosin and supraventricular tachycardia. New Engl J Med 325:1621–1627PubMedCrossRefGoogle Scholar
  10. 9.
    Clark RH, Kueser TJ, Walker MW et al. (2000) Low-dose nitric oxide therapy for persistent pulmonanary hypertension of the newborn IV. New Engl J Med 342:469–474PubMedCrossRefGoogle Scholar
  11. 10.
    Clyman RI (1996) Recommendations for the postnatal use of indomethacin: An analysis of four treatment strategies. Pediatr 128:601–607CrossRefGoogle Scholar
  12. 11.
    Davidson D, Barefield ES, Kattwinkel J, Dudell G, Damask M, Straube R, Rhines J, Chang CT(1998) Inhaled nitric oxide for the treatment of persistent pulmonary hypertension of the term newborn: a randomized double-masked, placebo-controlled, dose-response, multicenter study. Pediatrics 101:325–34PubMedCrossRefGoogle Scholar
  13. 12.
    De Carolis MP, Ramaguoli C, Polilmeni V et al. (2000) Prophylactic ibupr-ofen therapy of patent ductus arteriosus in preterm infants. Eur J Pediatr 159:364–368PubMedCrossRefGoogle Scholar
  14. 13.
    Esscher E, Michaelsson M, Smedy B (1975) Cardiovascular malformation in infant death. Br Heart J 37:824–829PubMedCrossRefGoogle Scholar
  15. 14.
    Fineman JR, Soifer SJ, Heymann MA (1995) Regulation of pulmonary vascular tone in the perinatal period. Annu Rev Physiol 57:115–134PubMedCrossRefGoogle Scholar
  16. 15.
    Fleming WH, Sarafian LB, Kobayashi RH (1984) Prostaglandin El therapy; is it associated with a higher incidence of wound infection in the cyanotic neonate? Chest 85:241–243PubMedCrossRefGoogle Scholar
  17. 16.
    Fowlie PW (1996) Prophylactic indomethacin: systematic review and meta-analysis. Arch Dis Child 74:F81-F87CrossRefGoogle Scholar
  18. 17.
    Fowlie PW (1997) Intravenous indomethacin for preventing mortality and morbidity in very low birth weight infants. Cochrane Database Syst Rev CD000174Google Scholar
  19. 18.
    Freedom RM, Smallhorn JF, Trusler JA (1992) Transposition of the great arteries. In: Freedom RM, Benson LN, Smallhorn JF (eds) Neonatal heart disease. Springer, Berlin Heidelberg New York Tokyo, pp 179–212Google Scholar
  20. 19.
    Frosteil CG, Fratacci MD, Wain JC, Jones R, Zapol WM (1991) Inhaled nitric oxide: A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 83:2083–2047CrossRefGoogle Scholar
  21. 20.
    Garson A Jr (1984) Arrhythmias in pediatric patients. Med Clin North Am 68:1187–1195Google Scholar
  22. 21.
    Gatzoulis MA, Rigby ML, Shinebourne EA, Redington AN (1995) Contemporary results of balloon valvuloplasty and surgical valvotomy for congenital aortic stenosis. Arch Dis Child 73:66–69PubMedCrossRefGoogle Scholar
  23. 22.
    Gildein HP, Kleinert S, Weintraub RG, Wilkinson JL, Karl TR, Mee RB (1996) Surgical commissurotomy of the aortic valve: outcome of open valvotomy in neonates with critical aortic stenosis. Am Heart J 131:754–759PubMedCrossRefGoogle Scholar
  24. 23.
    Gillette PC, Ross BA, Fyfe DA, Dudeles D, Zeigler V, Harold M (1988) Neonatal cardiac arrhythmias and their potential role in sudden infant death syndrome. Clin Perinat 15:699–712Google Scholar
  25. 24.
    Gingell RL (1992) Developmental biology of mammalian myocardium. In: Freedom RM, Benson LN, Smallhorn JF (eds) Neonatal heart disease. Springer, Berlin Heidelberg New York Tokyo, pp 35–44CrossRefGoogle Scholar
  26. 25.
    Green TP, Thompson TR, Johnson DE, Lock JE (1983) Furosemide promo- I tes patent ductus arteriosus in premature infants with the respiratory dist- I ress syndrome. New Engl J Med 308:743–748PubMedCrossRefGoogle Scholar
  27. 26.
    Hammerman C, Aramburo MJ (1990) Prolonged indomethacin therapy for the prevention of recurrence of patent ductus arteriosus. J Pediatr 117: 771–776PubMedCrossRefGoogle Scholar
  28. 27.
    Hammerman C, Yousefzadeh D, Choi J-H, Bui K-C (1989) Persistent pulmonary hypertension of the newborn. Clin Perinatol 16:137–156PubMedGoogle Scholar
  29. 28.
    Jenkins PC, Flanagan MF, Jenkins KJ et al. (2000) Survival analysis and risk factors for mortality in transplantation and stage surgery for hypoplastic left heart syndrome. J Am Coll Cardiol 36:1178–1185PubMedCrossRefGoogle Scholar
  30. 29.
    Kelley JG (1986) Digoxin receptors in the neonate. In: Doyle EF, Engle MA, Gersony WM, Rashkind WJ, Talner NS (eds) Pediatric cardiology. Springer, Berlin Heidelberg New York Tokyo, pp 1233 ffCrossRefGoogle Scholar
  31. 30.
    Kidd BSL (1978) Complete transposition of the great arteries. In: Keith JD, Rowe RJ, Vlad P (eds) Heart disease in infancy and childhood, 3rd edn. Macmillan, New York, p 628Google Scholar
  32. 31.
    Klopfenstein HS, Rudolph AM (1978) Postnatal changes in the circulation and response to volume overload in sheep. Circ Res 42:839–845PubMedCrossRefGoogle Scholar
  33. 32.
    Krogmann ON, Rammos S, Heusch A, Bourgeois M (1992) Rhythmusstörungen im Kindesalter. Monatsschr Kinderheilkd 140:F83-F97PubMedGoogle Scholar
  34. 33.
    Lewis AB, Freed MD, Heymann MA, Roehl SL, Kensey RC (1981) Side effects of therapy with prostaglandin El in infants with critical congenital heart disease. Circulation 64:893–898PubMedCrossRefGoogle Scholar
  35. 34.
    Long WA (1990) Persistent pulmonary hypertension of the newborn syndrome (PPHNS). In: Long WA (ed) Fetal and neonatal cardiology. Saunders, Philadelphia, pp 627–655Google Scholar
  36. 35.
    Ment LR, Westerveld M, Makuch R, Vohr B, Allan WC (1998) Cognitive outcome at 41/2 years of very low birth weight infants enrolled in the multi-center indomethacin intraventricular hemorrhage prevention trial. Pediatrics 102:150–160CrossRefGoogle Scholar
  37. 36.
    Ment LR, Vohr B, Allan W et al. (2000) Outcome of children in the indo-metacin intraventricular hemorrhage prevention trial. Pediatrics 105: 485–491PubMedCrossRefGoogle Scholar
  38. 37.
    Mosca F, Bray M, Lattanzio M, Fumagalli M, Tosetto C (1997) Comparative evaluation of the effects of indomethacin und ibuprofen on cerebral perfusion and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. J Pediatr 131:549–554PubMedCrossRefGoogle Scholar
  39. 38.
    Osiovich H, Phillipos E, Byrne P, Robertson M (2000) Hypoplastic left heart syndrome: „to treat or not to treat“. J Perinatol 20:363–365PubMedCrossRefGoogle Scholar
  40. 39.
    Quinton DN, O’Byrne G, Aitkenhead AR (1987) Comparison of endotracheal and peripheral intravenous adrenalin in cardiac arrest. Lancet 1:828–829PubMedCrossRefGoogle Scholar
  41. 40.
    Roberts JD, Polaner DM, Lang P, Zapol WM (1992) Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340:818–819PubMedCrossRefGoogle Scholar
  42. 41.
    Roberts, JDJ et al. (for the INHALED Nitric Oxide Study Group) (1997) Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. New Engl J Med 336:605–610PubMedCrossRefGoogle Scholar
  43. 42.
    Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM (1993) Inhaled nitric oxide for the adult respiratory distress syndrome. New Engl Med 328:399–405CrossRefGoogle Scholar
  44. 43.
    Samánek M, Goetzová J, Benesova D (1986) Causes of death in neonates with a heart malformation. Int J Cardiol 11:63–74PubMedCrossRefGoogle Scholar
  45. 44.
    Schneider M, Kampmann C, Schulze-Neick I, Hausdorf G, Lange PE (1993) Antegrade Ballonvalvuloplastie einer kritischen Aortenstenose bei einem 1820 g schweren Säugling. Z Kardiol 82:131–134PubMedGoogle Scholar
  46. 45.
    Schneider M, Zartner P, Sideropoulos A, Konertz W, Hansdorf G (1998) Stent implantation of the arterial duct in newborns with duct-dependent circulation. Eur Heart J 19:1401–1409PubMedCrossRefGoogle Scholar
  47. 46.
    Stahlman MT (1987) Persistent pulmonary hypertension of the newborn. In: Avery GB (ed) Neonatology, 3rd edn. Lippincott, Philadelphia, pp 422–424Google Scholar
  48. 47.
    Steinhoff HH (1987) Einfluß von Dopamin und Dobutamin auf die Nierenfunktion. Krankenhausarzt 60:362–365Google Scholar
  49. 48.
    Thanapoulos BD, Andreon A, Frunos C (1987) Prostaglandin E2 administration in infants with ductus-dependent cyanotic heart disease. J Pediatr 146:279–282Google Scholar
  50. 49.
    Toomasian JM, Snedecor SM, Cornell RG, Cilley RE, Bartlett RH (1988) National experience with extracorporal membrane oxygenation for newborn respiratory failure. Am Soc Artif Intern Organ Trans 34:140–147CrossRefGoogle Scholar
  51. 50.
    Van Overmeire B, Smets K, Lecoutere D, Van de Broek H, Weyler J, Degroote K, Langhendries JP (2000) A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. New Engl J Med 343:674–681PubMedCrossRefGoogle Scholar
  52. 51.
    Walsh-Sukys M (1993) Persistent pulmonary hypertension of the newborn: The black box revisited. Clin Perinat 20:127–143Google Scholar
  53. 52.
    Wernovsky G, Stiles KM, Gauvreau K et al. (2000) Cognitive development after the Fontan operation. Circulation 102:883–889PubMedCrossRefGoogle Scholar
  54. 53.
    Zeevi B, Keane JF, Castaneda AR, Perry SB, Lock JE (1989) Neonatal critical valvar aortic stenosis. A comparison of surgical and balloon dilatation therapy. Circulation 80:831–839PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2002

Authors and Affiliations

  • G. Bein

There are no affiliations available

Personalised recommendations